AJ

Arkadiusz Jozef Wojtasik

Active Director Director DIN 10744669
DIN 10744669 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Arkadiusz Jozef Wojtasik

Data last updated:

Arkadiusz Jozef Wojtasik is a Director at Proteon Pharmaceuticals India Private Limited (since 2024). The company operates in Pharma. Proteon Pharmaceuticals India Private Limited reported revenue of ₹2.17 Cr (FY 2024).

DIN 10744669
Primary Designation Director
Industry Pharma
First Appointment 15 Aug 2024
Oldest Company Age 8 yrs
Largest company Proteon Pharmaceuticals India Private Limited · ₹2.17 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Aug 20242017₹2.17 Cr (FY 2024)Active

Board colleagues of Arkadiusz Jozef Wojtasik

Directorship timeline

Open interactive timeline →
Proteon Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Arkadiusz Jozef Wojtasik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arkadiusz Jozef Wojtasik

Arkadiusz Jozef Wojtasik currently holds 1 directorship: Proteon Pharmaceuticals India Private Limited (Director, since 15 Aug 2024, revenue ₹2.17 Cr (FY 2024)).

Arkadiusz Jozef Wojtasik was first appointed on 15 Aug 2024 as Director at Proteon Pharmaceuticals India Private Limited.

The current boards of Arkadiusz Jozef Wojtasik's companies include Marcio Caparroz Lopes Pinheiro (Proteon Pharmaceuticals India Private Limited), Pradnya Raju Wakle (Proteon Pharmaceuticals India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available